Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasea for PONV in facial bone fracture surgery
NCT01637545Phase 4Terminated
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2011
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramosetron in postoperative nausea and vomiting (PONV), sponsored by Seoul National University Hospital. Started Dec 2011; status: terminated.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01637545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637545.